Psychological and psychopharmacologic interventions in adult patients with common mental disorders (mainly depressive and anxiety disorders) Mental and Behavioural Disorders
Conditions
Interventions
285 patients attending six Mental Health Centers for the first time are randomly assigned to two treatment groups, 148 to the experimental group and 137 to the control group.
A brief
Sponsors
Unidad de Coordinación de salud mental del Principado de Asturias (Mental Health Coordination Unit of the Healthcare Services of the Principality of Asturias)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The sample is randomly selected from among the people referred from primary care to six mental health centers of the public health services of the Principality of Asturias: 1. Over 18 years old 2. Go to that CSM for the first time 3. Diagnosed according to ICD-10 of depressive or anxiety disorders 4. Attend at least at one consultation with the therapist 5. Agree to participate in the research
Exclusion criteria
Exclusion criteria: 1. Diagnosed according to ICD-10 criteria of organic mental disorder, psychosis, addictions, eating disorder, mental retardation, psychological development disorder or serious personality disorder (Paranoid, Schizoid, Disocial and Emotional Instability) 2. Have made a serious suicide attempt in the previous 6 months 3. No required specialized care (those cases that do not require treatment are excluded)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The result or dependent variables (more than 20) are recorded at each timepoint of follow-up. They analyze the clinical-administrative result, the clinical and disability status, treatment in Primary Care, work situation, consumption of psychotropic drugs, satisfaction, etc. The fundamentals and the measurement instruments used are described below: 1. Clinical-administrative results: describes the status of the patient regarding treatment at the Mental Health center and consists of the following categories: Continues treatment, Discharge (the patient has been discharged by his/her reference therapist), Abandonment (the patient interrupts treatment against the opinion of the therapist or without having consulted him), Return and Others. Measured at 6, 12, 24 and 36 months after the start of treatment. 2. Clinical status according to the patient evaluated using three scales at 6, 12 and 24 months after the start of treatment. In the second phase it is measured also before the start of treatment: 2.1. Severity scale of the Clinical Global Impression of Severity (CGI-G) 2.2. Scale of change or improvement of the Clinical Global Impression of Change (CGI-C) 2.3. Symptom Check List-90 (SCL-90-R). Three global indices are obtained: Global Severity Index (GSI), Total Positive Symptoms (PST) and Positive Distress Index (PSDI). 3. Degree of disability according to the patient assessed using the Sheehan Disability Inventory at 6, 12 and 24 months after the start of treatment. In the second phase it is also measured before the start of treatment 4. Consumption of psychotropic drugs: only antidepressant drugs and benzodiazepines are analyzed because the consumption of other psychotropic drugs is minimal. The amounts have been standardized according to the equivalence of each medication with the reference drug in each group (equivalence in milligrams of imipramine in t | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction with the treatment evaluated using the Satisfaction Questionnaire by Moré and Muñoz (2000) at the end of the treatment | — |
Countries
Spain
Contacts
Public ContactMarco Antonio Luengo Castro
Outcome results
None listed